MD

Mark Dean

EX Exelixis: 1 patents #9 of 34Top 30%
Overall (2021): #353,232 of 548,734Top 65%
1
Patents 2021

Issued Patents 2021

Patent #TitleCo-InventorsDate
11141413 Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate Dana T. Aftab, Gisela Schwab, Colin Hessel, Christian Scheffold, Steven Lacy +2 more 2021-10-12